Open AccessPhase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Author(s) -
Ayca Gucalp,
Sara M. Tolaney,
Steven J. Isakoff,
James N. Ingle,
Minetta C. Liu,
Lisa A. Carey,
Kimberly Blackwell,
Hope S. Rugo,
Lisle M. Nabell,
Andres Forero,
Vered Stearns,
Ashley S. Doane,
Michael Danso,
Mary Ellen Moynahan,
Lamia F. Momen,
Joseph M. Gonzalez,
Arooj Akhtar,
Dilip Giri,
Sujata Patil,
Kimberly N. Feigin,
Clifford A. Hudis,
Tiffany A. Traina
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/gpkf-am90
Subject(s) - bicalutamide , androgen receptor , estrogen receptor , breast cancer , oncology , medicine , metastatic breast cancer , estrogen , cancer , prostate cancer , endocrinology , cancer research